ACORQ — Acorda Therapeutics Share News
0.000.00%
Last trade - 00:00- $0.02m
- $182.13m
- $117.63m
Brief: Acorda Says Debtors Did Not Receive More Than One Qualified Bid Before Bid Deadline, In Connection With Chapter 11 Proceedings
Live Markets: Biotech companies in 'Darwinian' world as cash remains king
U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease (updated)
U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease
Brief: Acorda Therapeutics Announces Nasdaq Delisting Notification
U.S. STOCKS ON THE MOVE-Paychex, ChampionX, EV stocks
U.S. STOCKS ON THE MOVE-VirTra, GE Vernova, Blackstone
U.S. STOCKS ON THE MOVE-PVH, Verve Therapeutics, Canoo
U.S. STOCKS ON THE MOVE-PVH Corp, oil companies, health insurers
Acorda Therapeutics plunges on Chapter 11 bankruptcy filing
Brief: Acorda Therapeutics Files For Voluntary Chapter 11 Protection
Brief: Acorda Therapeutics Files For Voluntary Chapter 11 Bankruptcy - Court Filing
Brief: Acorda Therapeutics Q3 Net Income USD -8.888 Million
Brief: Acorda Therapeutics Announces Biopas Laboratories Submission to Regulatory Agencies in 6 Latin American Countries for INBRIJA Approval
Brief: Acorda Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement
Brief: Acorda Therapeutics To Conduct 1-For-20 Reverse Stock Split
Brief: Acorda Therapeutics Reports First Quarter 2023 Financial Results
Brief: Acorda Therapeutics Inc Will Make Cash Interest Payment Of About $6.2 Million Due On June 1, 2023 Under Its Convertible Senior Secured Notes Indenture
U.S. STOCKS ON THE MOVE-Tyson Foods, Estee Lauder, Energy stocks